[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:il15-gene":3},{"name":4,"total":5,"recruiting":5,"trials":6},"IL15 Gene",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07355205","First-Line Ipilimumab Plus Nivolumab and Nogapendekin Alfa Inbakicept (N-803) in Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer",[11],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:17:03.534765Z","2026-07-05T05:32:16.677180Z"]